Show simple item record

dc.contributor.authorBjurlin, Marc A
dc.contributor.authorTanquilut, Eugene M
dc.contributor.authorSubram, Aswath
dc.contributor.authorKalkounos, Peggy
dc.contributor.authorMerlotti, Gary J
dc.date.accessioned2012-02-01T10:45:10Z
dc.date.available2012-02-01T10:45:10Z
dc.date.issued2012-02-01T10:45:10Z
dc.identifier.citationSurg Innov. 2009 Jun;16(2):147-54. Epub 2009 May 14.en_GB
dc.identifier.issn1553-3506 (Print)en_GB
dc.identifier.issn1553-3506 (Linking)en_GB
dc.identifier.pmid19443864en_GB
dc.identifier.doi10.1177/1553350609335277en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207803
dc.description.abstractEndovascular stent graft treatment of acute thoracic aortic transections is an encouraging minimally invasive alternative to open surgical repair. Between 2006 and 2008, 16 patients with acute thoracic aortic transections underwent evaluation at our institution. Seven patients who were treated with an endovascular stent graft were reviewed. The mean Glasgow Coma Score was 13.0, probability of survival was .89, and median injury severity score was 32. The mean number of intensive care unit days was 7.7, mean number of ventilator support days was 5.4, and hospital length of stay was 10 days. Mean blood loss was 285 mL, and operative time was 143 minutes. Overall mortality was 14%. Procedure complications were a bleeding arteriotomy site and an endoleak. Endovascular treatment of traumatic thoracic aortic transections appears to demonstrate superior results with respect to mortality, blood loss, operative time, paraplegia, and procedure-related complications when compared with open surgical repair literature.
dc.language.isoengen_GB
dc.subject.meshAdolescenten_GB
dc.subject.meshAdulten_GB
dc.subject.mesh*Angioplastyen_GB
dc.subject.meshAorta, Thoracic/*injuriesen_GB
dc.subject.meshAortic Rupture/diagnosis/etiology/*surgeryen_GB
dc.subject.mesh*Blood Vessel Prosthesis Implantationen_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshRetrospective Studiesen_GB
dc.subject.mesh*Stentsen_GB
dc.subject.meshTreatment Outcomeen_GB
dc.subject.meshVascular Patencyen_GB
dc.subject.meshWounds, Nonpenetrating/*complications/diagnosis/surgeryen_GB
dc.subject.meshYoung Adulten_GB
dc.titleEndovascular stent graft treatment of acute thoracic aortic transections due to blunt force trauma.en_GB
dc.contributor.departmentDivision of Trauma, St. James Hospital and Health Centers, Midwestern University,, Olympia Fields, Illinois, USA.en_GB
dc.identifier.journalSurgical innovationen_GB
dc.description.provinceLeinster
html.description.abstractEndovascular stent graft treatment of acute thoracic aortic transections is an encouraging minimally invasive alternative to open surgical repair. Between 2006 and 2008, 16 patients with acute thoracic aortic transections underwent evaluation at our institution. Seven patients who were treated with an endovascular stent graft were reviewed. The mean Glasgow Coma Score was 13.0, probability of survival was .89, and median injury severity score was 32. The mean number of intensive care unit days was 7.7, mean number of ventilator support days was 5.4, and hospital length of stay was 10 days. Mean blood loss was 285 mL, and operative time was 143 minutes. Overall mortality was 14%. Procedure complications were a bleeding arteriotomy site and an endoleak. Endovascular treatment of traumatic thoracic aortic transections appears to demonstrate superior results with respect to mortality, blood loss, operative time, paraplegia, and procedure-related complications when compared with open surgical repair literature.


This item appears in the following Collection(s)

Show simple item record